Cellendes
Private Company
Funding information not available
Overview
Cellendes GmbH is a privately-held tools and reagents company based in Reutlingen, Germany, serving the cell therapy and regenerative medicine research sectors. The company's flagship '3-D Life' technology platform offers a modular, chemically-defined hydrogel system that allows users to create tunable, biomimetic 3D cell culture environments without animal-derived components. Its products are used in academic and industrial research for applications like organoid culture, disease modeling, and drug screening. Cellendes generates revenue through the sale of hydrogel kits and components directly to researchers.
Technology Platform
The 3-D Life Biomimetic Hydrogel System: A modular platform using synthetic polymers (PVA, PEG, dextran) that covalently crosslink at ambient temperature to form tunable, animal-free hydrogels. It allows user-defined incorporation of biomimetic peptides (e.g., for adhesion, MMP-sensitivity) to create customized 3D cell culture environments.
Opportunities
Risk Factors
Competitive Landscape
Cellendes competes in the 3D cell culture scaffold market against major players like Corning (Matrigel, Collagen), Thermo Fisher Scientific, and Merck, as well as specialized firms like Advanced BioMatrix and UPM Biomedicals. Its key differentiation is the synthetic, highly tunable, and animal-free nature of its hydrogel system, targeting researchers needing precise microenvironments over off-the-shelf natural extracts.